Cwm, LLC Prelude Therapeutics Inc Transaction History
Cwm, LLC
- $25.1 Billion
- Q1 2025
A detailed history of Cwm, LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Cwm, LLC holds 3,346 shares of PRLD stock, worth $2,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,346
Previous 1,899
76.2%
Holding current value
$2,877
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRLD
# of Institutions
57Shares Held
29.7MCall Options Held
6.4KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$9.38 Million0.38% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$8.71 Million0.14% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$919,2670.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.03MShares$885,1110.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$868,9370.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $31.3M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...